2026 Latest market price update for tenofovir alafenamide tablets (Vemlidy)

Tenofovir alafenamide fumarate tablets (Vemlidy/Vemlidy) is an anti- hepatitis B virus drug, and its global price varies depending on the region and manufacturer. In the Chinese market, the price of tenofovir alafenamide fumarate tablets is relatively affordable. According to the latest market information, the price of the original drug is 25mg*30 tablets per box, which is about more than 500 yuan. This drug has been included in the list of Class B medical insurance drugs, which provides protection for the treatment of the majority of hepatitis B patients. Medical insurance coverage allows patients to enjoy a lower drug cost burden during treatment, especially for those patients who require antiviral treatment for a long time, the financial burden is relatively easy.

In the international market, the price of tenofovir alafenamide fumarate tablets is relatively high. In the markets of developed countries such as the United States, the price of 25mg oral tablets will jump to more than 1,000 US dollars (30 tablets per box), which puts some patients under greater pressure on drug costs. This price difference is mainly affected by factors such as production costs, market demand, tax policies and exchange rate fluctuations.

In addition to the original drug, generic versions of tenofovir alafenamide fumarate tablets are also produced globally. Pharmaceutical manufacturers in countries such as India, Laos and Bangladesh, such as Mylan Pharmaceuticals, ASEAN Pharmaceuticals and Beacon Pharmaceuticals, produce relatively cheap generic drugs, with prices generally exceeding RMB 100 per box. Specific prices will fluctuate due to exchange rate changes. Although generic drugs are similar in quality to brand-name drugs, patients should still choose drugs under the guidance of their doctors.

Overall, the price of tenofovir alafenamide tablets varies due to production, policies and demand differences in different countries and regions. Drug prices in the domestic market are relatively low, and medical insurance reimbursement provides patients with more affordable costs.

Reference materials:https://www.vemlidyhcp.com/